Malignant Pancreatic Neoplasm clinical trials
7 active trials name this condition. Describe your situation to see which ones look like a fit.
- Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
- Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
- Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
- Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant Pancreatic Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.